Works matching IS 22351795 AND DT 2020 AND VI 9 AND IP 1
Results: 17
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 1, doi. 10.1159/000506214
- Publication type:
- Article
APPLE News.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 117, doi. 10.1159/000505824
- Publication type:
- Article
Management of Hepatocellular Carcinoma in Japan: Current Trends.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 93, doi. 10.1159/000504624
- By:
- Publication type:
- Article
Reply to the Letter to the Editor Entitled "Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?".
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 110, doi. 10.1159/000504301
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2020
- Publication type:
- Correction Notice
Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 15, doi. 10.1159/000503719
- By:
- Publication type:
- Article
Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition).
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 28, doi. 10.1159/000503685
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 84, doi. 10.1159/000503577
- By:
- Publication type:
- Article
Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031
- By:
- Publication type:
- Article
Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 63, doi. 10.1159/000502774
- By:
- Publication type:
- Article
Response to the Letter to the Editor Concerning the Publication "Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma".
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 107, doi. 10.1159/000502745
- By:
- Publication type:
- Article
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 50, doi. 10.1159/000502744
- By:
- Publication type:
- Article
Mean Platelet Volume and Unresectable Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 41, doi. 10.1159/000502479
- By:
- Publication type:
- Article
Waist Circumference and Risk of Liver Cancer: A Systematic Review and Meta-Analysis of over 2 Million Cohort Study Participants.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 6, doi. 10.1159/000502478
- By:
- Publication type:
- Article